Advertisement

Contemporary Approach to Chronic Total Occlusion Interventions

  • Mahesh Anantha-Narayanan
  • Santiago GarciaEmail author
Coronary Artery Disease (D Feldman and V Voudris, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Coronary Artery Disease

Abstract

Purpose of review

Chronic total occlusion (CTO) poses one of the greatest technical challenges to interventional cardiologists. Despite recent advancements in techniques and clinical trials showing significant benefits of CTO percutaneous coronary interventions (PCI), the proportion of patients with untreated CTOs remains high. We therefore aim to perform a comprehensive review of the various techniques available, recent advancements, benefits, and complications associated with CTO PCI.

Recent findings

Three randomized clinical trials examining the benefits of CTO PCI have recently been presented. Scoring systems have been developed to facilitate pre-procedural estimation of success and complications of CTO PCI. Technological enhancements in coronary wires and other interventional equipment along with dedicated training for CTO operators have improved the likelihood of successful recanalization of CTOs.

Summary

CTO PCI has been shown to improve patient symptoms and quality of life. It is therefore important to have an in-depth knowledge of the various CTO techniques, appropriate equipment, and complications when performing these complex procedures. Clinicians should weigh the risks and benefits and choose the appropriate patient population who may benefit from revascularization.

Keywords

Chronic total occlusions Percutaneous coronary interventions Revascularization Coronary artery disease Coronary angiogram Myocardial infarction 

Notes

Compliance With Ethical Standards

Conflict of Interest

Mahesh Anantha Narayanan declares no potential conflicts of interest. Santiago Garcia is a consultant for Surmodics, Osprey medical, Medtronic, Edwards Lifesciences, Abbott and Boston Scientific. Research grants from Edwards Life Sciences, Minnesota Veterans Research Foundation and VA Office of Research and Development.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Garcia S, Abdullah S, Banerjee S, Brilakis ES. Chronic total occlusions: patient selection and overview of advanced techniques. Curr Cardiol Rep. 2013;15(2):334.CrossRefGoogle Scholar
  2. 2.
    Shah PB. Management of coronary chronic total occlusion. Circulation. 2011;123(16):1780–4.CrossRefGoogle Scholar
  3. 3.
    Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355(23):2395–407.CrossRefGoogle Scholar
  4. 4.
    George S, Cockburn J, Clayton TC, Ludman P, Cotton J, Spratt J, et al. Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database. J Am Coll Cardiol. 2014;64(3):235–43.CrossRefGoogle Scholar
  5. 5.
    Ladwiniec A, Allgar V, Thackray S, Alamgir F, Hoye A. Medical therapy, percutaneous coronary intervention and prognosis in patients with chronic total occlusions. Heart. 2015;101(23):1907–14.CrossRefGoogle Scholar
  6. 6.
    Tomasello SD, Boukhris M, Giubilato S, Marzà F, Garbo R, Contegiacomo G, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J. 2015;36(45):3189–98.CrossRefGoogle Scholar
  7. 7.
    • Råmunddal T, Hoebers LP, Henriques JP, Dworeck C, Angerås O, Odenstedt J, et al. Prognostic impact of chronic total occlusions: a report from SCAAR (Swedish Coronary Angiography and Angioplasty Registry). JACC Cardiovasc Interv. 2016;9(15):1535-44. The Swedish registry studied 14, 441 patients with CTO and reported higher mortality with CTO interventions. This data highlighted the importance of appropriate patient selection and operator expertise in CTO PCIs.Google Scholar
  8. 8.
    Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Osherov AB, Yalonetsky S, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012;59(11):991–7.CrossRefGoogle Scholar
  9. 9.
    Wolff R, Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Sparkes JD, et al. Gender differences in the prevalence and treatment of coronary chronic total occlusions. Catheter Cardiovasc Interv. 2016;87(6):1063–70.CrossRefGoogle Scholar
  10. 10.
    Claessen BE, Hoebers LP, van der Schaaf RJ, Kikkert WJ, Engstrom AE, Vis MM, et al. Prevalence and impact of a chronic total occlusion in a non-infarct-related artery on long-term mortality in diabetic patients with ST elevation myocardial infarction. Heart. 2010;96(24):1968–72.CrossRefGoogle Scholar
  11. 11.
    Claessen BE, Dangas GD, Weisz G, Witzenbichler B, Guagliumi G, Möckel M, et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur Heart J. 2012;33(6):768–75.CrossRefGoogle Scholar
  12. 12.
    Claessen BE, van der Schaaf RJ, Verouden NJ, Stegenga NK, Engstrom AE, Sjauw KD, et al. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2009;2(11):1128–34.CrossRefGoogle Scholar
  13. 13.
    • Hoebers LP, Claessen BE, Elias J, Dangas GD, Mehran R, Henriques JP. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol. 2015;187:90–6 Meta analysis of 34 PCI CTO studies showed improvement in left ventricular ejection fraction and improvement in survival, which has not been proven in randomized trials yet.CrossRefGoogle Scholar
  14. 14.
    Choi IJ, Koh YS, Lim S, Choo EH, Kim JJ, Hwang BH, et al. Impact of percutaneous coronary intervention for chronic total occlusion in non-infarct-related arteries in patients with acute myocardial infarction (from the COREA-AMI Registry). Am J Cardiol. 2016;117(7):1039–46.CrossRefGoogle Scholar
  15. 15.
    Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018;39(26):2484–93.CrossRefGoogle Scholar
  16. 16.
    Kirschbaum SW, Baks T, van den Ent M, Sianos G, Krestin GP, Serruys PW, et al. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total coronary occlusions. Am J Cardiol. 2008;101(2):179–85.CrossRefGoogle Scholar
  17. 17.
    Baks T, van Geuns RJ, Duncker DJ, Cademartiri F, Mollet NR, Krestin GP, et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol. 2006;47(4):721–5.CrossRefGoogle Scholar
  18. 18.
    Sirnes PA, Myreng Y, Mølstad P, Bonarjee V, Golf S. Improvement in left ventricular ejection fraction and wall motion after successful recanalization of chronic coronary occlusions. Eur Heart J. 1998;19(2):273–81.CrossRefGoogle Scholar
  19. 19.
    Piscione F, Galasso G, De Luca G, Marrazzo G, Sarno G, Viola O, et al. Late reopening of an occluded infarct related artery improves left ventricular function and long term clinical outcome. Heart. 2005;91(5):646–51.CrossRefGoogle Scholar
  20. 20.
    Melchior JP, Meier B, Urban P, Finci L, Steffenino G, Noble J, et al. Percutaneous transluminal coronary angioplasty for chronic total coronary arterial occlusion. Am J Cardiol. 1987;59(6):535–8.CrossRefGoogle Scholar
  21. 21.
    Rossello X, Pujadas S, Serra A, Bajo E, Carreras F, Barros A, et al. Assessment of inducible myocardial ischemia, quality of life, and functional status after successful percutaneous revascularization in patients with chronic total coronary occlusion. Am J Cardiol. 2016;117(5):720–6.CrossRefGoogle Scholar
  22. 22.
    Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013;82(4):E266–355.PubMedGoogle Scholar
  23. 23.
    • Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619 The European guieline document given a class II a indication for CTO PCI in appropriately chosen patient population.CrossRefGoogle Scholar
  24. 24.
    Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2017;69(17):2212–41.CrossRefGoogle Scholar
  25. 25.
    Safley DM, Koshy S, Grantham JA, Bybee KA, House JA, Kennedy KF, et al. Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. Catheter Cardiovasc Interv. 2011;78(3):337–43.PubMedGoogle Scholar
  26. 26.
    • Brilakis ES, Banerjee S, Karmpaliotis D, Lombardi WL, Tsai TT, Shunk KA, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015;8(2):245–53 The authors evaluated the national cardiovascular data registry including 594,510 PCIs for stable angina and reported underutilization of CTO interventions, which led to further trials to evalute its safety and efficacy of CTO intervnetions.CrossRefGoogle Scholar
  27. 27.
    Kappetein AP, Dawkins KD, Mohr FW, Morice MC, Mack MJ, Russell ME, et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg. 2006;29(4):486–91.CrossRefGoogle Scholar
  28. 28.
    Patel VG, Brayton KM, Tamayo A, Mogabgab O, Michael TT, Lo N, et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 2013;6(2):128–36.CrossRefGoogle Scholar
  29. 29.
    Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM, et al. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol. 2015;198:222–8.CrossRefGoogle Scholar
  30. 30.
    Maeremans J, Walsh S, Knaapen P, Spratt JC, Avran A, Hanratty CG, et al. The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE registry. J Am Coll Cardiol. 2016;68(18):1958–70.CrossRefGoogle Scholar
  31. 31.
    Galassi AR, Boukhris M, Azzarelli S, Castaing M, Marzà F, Tomasello SD. Percutaneous coronary revascularization for chronic total occlusions: a novel predictive score of technical failure using advanced technologies. JACC Cardiovasc Interv. 2016;9(9):911–22.CrossRefGoogle Scholar
  32. 32.
    Wilson WM, Walsh SJ, Yan AT, Hanratty CG, Bagnall AJ, Egred M, et al. Hybrid approach improves success of chronic total occlusion angioplasty. Heart. 2016;102(18):1486–93.CrossRefGoogle Scholar
  33. 33.
    Habara M, Tsuchikane E, Muramatsu T, Kashima Y, Okamura A, Mutoh M, et al. Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry. Catheter Cardiovasc Interv. 2016;87(6):1027–35.CrossRefGoogle Scholar
  34. 34.
    Morino Y, Abe M, Morimoto T, Kimura T, Hayashi Y, Muramatsu T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (multicenter CTO registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv. 2011;4(2):213–21.CrossRefGoogle Scholar
  35. 35.
    • Christopoulos G, Kandzari DE, Yeh RW, Jaffer FA, Karmpaliotis D, Wyman MR, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score. JACC Cardiovasc Interv. 2016;9(1):1–9 The trial introduced a novel scoring system for interventions in CTO and is one of the scores being widely used worldwide for CTO interventions.CrossRefGoogle Scholar
  36. 36.
    Forouzandeh F, Suh J, Stahl E, Ko YA, Lee S, Joshi U, et al. Performance of J-CTO and PROGRESS CTO scores in predicting angiographic success and long-term outcomes of percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2018;121(1):14–20.CrossRefGoogle Scholar
  37. 37.
    Alessandrino G, Chevalier B, Lefèvre T, Sanguineti F, Garot P, Unterseeh T, et al. A clinical and angiographic scoring system to predict the probability of successful first-attempt percutaneous coronary intervention in patients with total chronic coronary occlusion. JACC Cardiovasc Interv. 2015;8(12):1540–8.CrossRefGoogle Scholar
  38. 38.
    Ellis SG, Burke MN, Murad MB, Graham JJ, Badawi R, Toma C, et al. Predictors of successful hybrid-approach chronic total coronary artery occlusion stenting: an improved model with novel correlates. JACC Cardiovasc Interv. 2017;10(11):1089–98.CrossRefGoogle Scholar
  39. 39.
    Henriques JP, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. J Am Coll Cardiol. 2016;68(15):1622–32.CrossRefGoogle Scholar
  40. 40.
    Hannan EL, Zhong Y, Jacobs AK, Stamato NJ, Berger PB, Walford G, et al. Patients with chronic total occlusions undergoing percutaneous coronary interventions: characteristics, success, and outcomes. Circ Cardiovasc Interv. 2016;9(5):e003586.Google Scholar
  41. 41.
    Kinnaird T, Anderson R, Ossei-Gerning N, Gallagher S, Large A, Strange J, et al. Vascular access site and outcomes among 26,807 chronic total coronary occlusion angioplasty cases from the British Cardiovascular Interventions Society National Database. JACC Cardiovasc Interv. 2017;10(7):635–44.CrossRefGoogle Scholar
  42. 42.
    Fairley SL, Lucking AJ, McEntegart M, Shaukat A, Smith D, Chase A, et al. Routine use of fluoroscopic-guided femoral arterial puncture to minimise vascular complication rates in CTO intervention: multi-centre UK experience. Heart Lung Circ. 2016;25(12):1203–9.CrossRefGoogle Scholar
  43. 43.
    Tanaka Y, Moriyama N, Ochiai T, Takada T, Tobita K, Shishido K, et al. Transradial coronary interventions for complex chronic total occlusions. JACC Cardiovasc Interv. 2017;10(3):235–43.CrossRefGoogle Scholar
  44. 44.
    Alaswad K, Menon RV, Christopoulos G, Lombardi WL, Karmpaliotis D, Grantham JA, et al. Transradial approach for coronary chronic total occlusion interventions: insights from a contemporary multicenter registry. Catheter Cardiovasc Interv. 2015;85(7):1123–9.CrossRefGoogle Scholar
  45. 45.
    Colombo A, Mikhail GW, Michev I, Iakovou I, Airoldi F, Chieffo A, et al. Treating chronic total occlusions using subintimal tracking and reentry: the STAR technique. Catheter Cardiovasc Interv. 2005;64(4):407–11 discussion 12.CrossRefGoogle Scholar
  46. 46.
    Galassi AR, Tomasello SD, Costanzo L, Campisano MB, Barrano G, Ueno M, et al. Mini-STAR as bail-out strategy for percutaneous coronary intervention of chronic total occlusion. Catheter Cardiovasc Interv. 2012;79(1):30–40.CrossRefGoogle Scholar
  47. 47.
    Badhey N, Lombardi WL, Thompson CA, Brilakis ES, Banerjee S. Use of the venture wire control catheter for subintimal coronary dissection and reentry in chronic total occlusions. J Invasive Cardiol. 2010;22(9):445–8.PubMedGoogle Scholar
  48. 48.
    Whitlow PL, Burke MN, Lombardi WL, Wyman RM, Moses JW, Brilakis ES, et al. Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs (facilitated antegrade steering technique in chronic total occlusions) trial. JACC Cardiovasc Interv. 2012;5(4):393–401.CrossRefGoogle Scholar
  49. 49.
    Carlino M, Demir OM, Colombo A, Azzalini L. Microcatheter knuckle technique: a novel technique for negotiating the subintimal space during chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2018;92:1256–60.CrossRefGoogle Scholar
  50. 50.
    Rathore S, Katoh O, Matsuo H, Terashima M, Tanaka N, Kinoshita Y, et al. Retrograde percutaneous recanalization of chronic total occlusion of the coronary arteries: procedural outcomes and predictors of success in contemporary practice. Circ Cardiovasc Interv. 2009;2(2):124–32.CrossRefGoogle Scholar
  51. 51.
    Ozawa N. A new understanding of chronic total occlusion from a novel PCI technique that involves a retrograde approach to the right coronary artery via a septal branch and passing of the guidewire to a guiding catheter on the other side of the lesion. Catheter Cardiovasc Interv. 2006;68(6):907–13.CrossRefGoogle Scholar
  52. 52.
    Karmpaliotis D, Michael TT, Brilakis ES, Papayannis AC, Tran DL, Kirkland BL, et al. Retrograde coronary chronic total occlusion revascularization: procedural and in-hospital outcomes from a multicenter registry in the United States. JACC Cardiovasc Interv. 2012;5(12):1273–9.CrossRefGoogle Scholar
  53. 53.
    • Brilakis ES, Grantham JA, Thompson CA, DeMartini TJ, Prasad A, Sandhu GS, et al. The retrograde approach to coronary artery chronic total occlusions: a practical approach. Catheter Cardiovasc Interv. 2012;79(1):3–19 An important manuscript that highlights the importance of the retrograde approach to CTO PCI and provides practical recopmmendations.CrossRefGoogle Scholar
  54. 54.
    Matsuno S, Tsuchikane E, Harding SA, Wu EB, Kao HL, Brilakis ES, et al. Overview and proposed terminology for the reverse controlled antegrade and retrograde tracking (reverse CART) techniques. EuroIntervention. 2018;14(1):94–101.CrossRefGoogle Scholar
  55. 55.
    • Brilakis ES, Grantham JA, Rinfret S, Wyman RM, Burke MN, Karmpaliotis D, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv. 2012;5(4):367–79 This article is the first description of the hybrid algorithm for CTO PCI.CrossRefGoogle Scholar
  56. 56.
    Patel MR, Marso SP, Dai D, Anstrom KJ, Shunk KA, Curtus JP, et al. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005–2008. JACC Cardiovasc Interv. 2012;5(10):1054–61.CrossRefGoogle Scholar
  57. 57.
    Saeed B, Kandzari DE, Agostoni P, Lombardi WL, Rangan BV, Banerjee S, et al. Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2011;77(3):315–32.CrossRefGoogle Scholar
  58. 58.
    Colmenarez HJ, Escaned J, Fernández C, Lobo L, Cano S, del Angel JG, et al. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(17):1854–66.CrossRefGoogle Scholar
  59. 59.
    Suttorp MJ, Laarman GJ, Rahel BM, Kelder JC, Bosschaert MA, Kiemeneij F, et al. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation. 2006;114(9):921–8.CrossRefGoogle Scholar
  60. 60.
    Moreno R, García E, Teles R, Rumoroso JR, Cyrne Carvalho H, Goicolea FJ, et al. Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial. Circ Cardiovasc Interv. 2013;6(1):21–8.CrossRefGoogle Scholar
  61. 61.
    Sherbet DP, Christopoulos G, Karatasakis A, Danek BA, Kotsia A, Navara R, et al. Optical coherence tomography findings after chronic total occlusion interventions: insights from the “AngiographiC evaluation of the everolimus-eluting stent in chronic total occlusions” (ACE-CTO) study (NCT01012869). Cardiovasc Revasc Med. 2016;17(7):444–9.CrossRefGoogle Scholar
  62. 62.
    • Riley RF, Sapontis J, Kirtane AJ, Karmpaliotis D, Kalra S, Jones PG, et al. Prevalence, predictors, and health status implications of periprocedural complications during coronary chronic total occlusion angioplasty. EuroIntervention. 2018. In this study, retrograde approach, increasing age, and increasing lesion complexity are associated with poor outcomes in CTO PCI, thus highlighting the importance of learning curve, adequate planning and choosing the right patient population. Google Scholar
  63. 63.
    Suero JA, Marso SP, Jones PG, Laster SB, Huber KC, Giorgi LV, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol. 2001;38(2):409–14.CrossRefGoogle Scholar
  64. 64.
    Safley DM, House JA, Marso SP, Grantham JA, Rutherford BD. Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel. JACC Cardiovasc Interv. 2008;1(3):295–302.CrossRefGoogle Scholar
  65. 65.
    Di Mario C, Werner GS, Sianos G, Galassi AR, Büttner J, Dudek D, et al. European perspective in the recanalisation of chronic total occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention. 2007;3(1):30–43.PubMedGoogle Scholar
  66. 66.
    Brilakis ES, Karmpaliotis D, Patel V, Banerjee S. Complications of chronic total occlusion angioplasty. Interv Cardiol Clin. 2012;1(3):373–89.PubMedGoogle Scholar
  67. 67.
    Ge L, Zhong X, Ma J, Fan B, Lu H, Qian J, et al. Safety and feasibility of a low frame rate protocol for percutaneous coronary intervention to chronic total occlusions: preliminary experience. EuroIntervention. 2018;14(5):e538–e45.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Cardiovascular Disease, Department of MedicineUniversity of MinnesotaMinneapolisUSA
  2. 2.Minneapolis Heart Institute at Abbott Northwestern HospitalMinneapolisUSA

Personalised recommendations